Minnesota legislators are reviving a proposal to raise millions of dollars to battle the opioid crisis by increasing fees on the companies that produce and distribute highly addictive prescription drugs.
The plan would infuse $20 million into a range of services, including addiction research, treatment and recovery programs and county-level social services for children who are neglected or abused by parents struggling with substance abuse. The increased funding would be paid for by a bump in annual fees on opioid manufacturers and distributors.
"This is an opportunity to save the lives and the futures of those who are still here," state Sen. Julie Rosen, R-Vernon Center, said Thursday in a statement. "We have a moral obligation to help end this crisis."
Legislators last year scrapped a proposal to charge opioid manufacturers a penny a pill to pay for treatment services after intense lobbying by pharmaceutical companies. A licensing fee measure also fell short.
Rosen said she feels the proposed increase will be much more acceptable to the industry and that she's been meeting with the pharmaceutical companies.
"They keep saying they want to be a part of the solution, and I keep saying how does that look?" Rosen said. "I'm still open to how that looks, and we can adjust as we're going."
A spokesman for PhRMA, the trade group representing drug manufacturers, said it has not seen details of the proposal and could not comment.
The opioid epidemic has hit crisis levels nationwide as communities across the country grapple with the effects of addiction and record overdose rates.